New study aims to predict Crohn's treatment success with simple scans and blood work
NCT ID NCT07246460
Summary
This study aims to find better ways to monitor how well a Crohn's disease drug (guselkumab) is working. Researchers will follow 90 adult patients for a year, using intestinal ultrasounds and blood tests to look for patterns linked to treatment success. The goal is to see if these non-invasive methods can reliably show when the drug is controlling the disease, potentially reducing the need for frequent colonoscopies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE OF BOTH SMALL AND LARGE INTESTINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
University of Calgary
RECRUITINGCalgary, Alberta, T3H 1S7, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.